Biomarkers for ovarian cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8682591
APP PUB NO 20120220476A1
SERIAL NO

13372137

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a method of qualifying ovarian cancer status in a subject comprising: (a) measuring at least one biomarker in a sample from the subject and (b) correlating the measurement with ovarian cancer status. The invention further relates to kits for qualifying ovarian cancer status in a subject.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASPIRA WOMEN'S HEALTH INC12117 BEE CAVES ROAD AUSTIN TX 78737

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chan, Daniel W Clarksville, US 29 333
Fung, Eric Los Altos, US 14 269
Meng, Xiao-Ying Fremont, US 12 197
Zhang, Zhen Dayton, US 498 4584

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 25, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00